158 related articles for article (PubMed ID: 33373491)
1. Safety of Oral Bisphosphonates in Moderate-to-Severe Chronic Kidney Disease: A Binational Cohort Analysis.
Robinson DE; Ali MS; Pallares N; Tebé C; Elhussein L; Abrahamsen B; Arden NK; Ben-Shlomo Y; Caskey FJ; Cooper C; Dedman D; Delmestri A; Judge A; Pérez-Sáez MJ; Pascual J; Nogues X; Diez-Perez A; Strauss VY; Javaid MK; Prieto-Alhambra D
J Bone Miner Res; 2021 May; 36(5):820-832. PubMed ID: 33373491
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study.
Robinson DE; Ali MS; Strauss VY; Elhussein L; Abrahamsen B; Arden NK; Ben-Shlomo Y; Caskey F; Cooper C; Dedman D; Delmestri A; Judge A; Javaid MK; Prieto-Alhambra D
Health Technol Assess; 2021 Mar; 25(17):1-106. PubMed ID: 33739919
[TBL] [Abstract][Full Text] [Related]
3. Oral Bisphosphonate Use and All-Cause Mortality in Patients With Moderate-Severe (Grade 3B-5D) Chronic Kidney Disease: A Population-Based Cohort Study.
Alarkawi D; Ali MS; Bliuc D; Pallares N; Tebe C; Elhussein L; Caskey FJ; Arden NK; Ben-Shlomo Y; Abrahamsen B; Diez-Perez A; Pascual J; Pérez-Sáez MJ; Center JR; Judge A; Cooper C; Javaid MK; Prieto-Alhambra D
J Bone Miner Res; 2020 May; 35(5):894-900. PubMed ID: 31968134
[TBL] [Abstract][Full Text] [Related]
4. Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database.
Khalid S; Calderon-Larranaga S; Sami A; Hawley S; Judge A; Arden N; Van Staa TP; Cooper C; Abrahamsen B; Javaid MK; Prieto-Alhambra D
Osteoporos Int; 2022 Jul; 33(7):1579-1589. PubMed ID: 35138412
[TBL] [Abstract][Full Text] [Related]
5. Bisphophonates in CKD patients with low bone mineral density.
Liu WC; Yen JF; Lang CL; Yan MT; Lu KC
ScientificWorldJournal; 2013; 2013():837573. PubMed ID: 24501586
[TBL] [Abstract][Full Text] [Related]
6. Hypocalcemia Risk of Denosumab Across the Spectrum of Kidney Disease: A Population-Based Cohort Study.
Cowan A; Jeyakumar N; McArthur E; Fleet JL; Kanagalingam T; Karp I; Khan T; Muanda FT; Nash DM; Silver SA; Thain J; Weir MA; Garg AX; Clemens KK
J Bone Miner Res; 2023 May; 38(5):650-658. PubMed ID: 36970786
[TBL] [Abstract][Full Text] [Related]
7. Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B-5) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, Denmark.
Ali MS; Ernst M; Robinson DE; Caskey F; Arden NK; Ben-Shlomo Y; Nybo M; Rubin KH; Judge A; Cooper C; Javaid MK; Hermann AP; Prieto-Alhambra D
Arch Osteoporos; 2020 Jun; 15(1):81. PubMed ID: 32483674
[TBL] [Abstract][Full Text] [Related]
8. Kidney, Cardiac, and Safety Outcomes Associated With α-Blockers in Patients With CKD: A Population-Based Cohort Study.
Hundemer GL; Knoll GA; Petrcich W; Hiremath S; Ruzicka M; Burns KD; Edwards C; Bugeja A; Rhodes E; Sood MM
Am J Kidney Dis; 2021 Feb; 77(2):178-189.e1. PubMed ID: 32920153
[TBL] [Abstract][Full Text] [Related]
9. Competing Risks of Fracture and Death in Older Adults with Chronic Kidney Disease.
Hall RK; Sloane R; Pieper C; Van Houtven C; LaFleur J; Adler R; Colón-Emeric C
J Am Geriatr Soc; 2018 Mar; 66(3):532-538. PubMed ID: 29319880
[TBL] [Abstract][Full Text] [Related]
10. The risk of new fragility fractures in patients with chronic kidney disease and hip fracture-a population-based cohort study in the UK.
de Bruin IJA; Wyers CE; Souverein PC; van Staa TP; Geusens PPMM; van den Bergh JPW; de Vries F; Driessen JHM
Osteoporos Int; 2020 Aug; 31(8):1487-1497. PubMed ID: 32266436
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonate use in chronic kidney disease: association with adynamic bone disease in a bone histology series.
Amerling R; Harbord NB; Pullman J; Feinfeld DA
Blood Purif; 2010; 29(3):293-9. PubMed ID: 20090316
[TBL] [Abstract][Full Text] [Related]
12. Oral bisphosphonate use in the elderly is not associated with acute kidney injury.
Shih AW; Weir MA; Clemens KK; Yao Z; Gomes T; Mamdani MM; Juurlink DN; Hird A; Hodsman A; Parikh CR; Wald R; Cadarette SM; Garg AX
Kidney Int; 2012 Oct; 82(8):903-8. PubMed ID: 22695327
[TBL] [Abstract][Full Text] [Related]
13. Association of Bisphosphonate Use and Risk of Revision After THA: Outcomes From a US Total Joint Replacement Registry.
Khatod M; Inacio MC; Dell RM; Bini SA; Paxton EW; Namba RS
Clin Orthop Relat Res; 2015 Nov; 473(11):3412-20. PubMed ID: 25896134
[TBL] [Abstract][Full Text] [Related]
14. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
Fu EL; Clase CM; Evans M; Lindholm B; Rotmans JI; Dekker FW; van Diepen M; Carrero JJ
Am J Kidney Dis; 2021 May; 77(5):719-729.e1. PubMed ID: 33246024
[TBL] [Abstract][Full Text] [Related]
15. Effect of Bisphosphonates on Fracture Outcomes Among Frail Older Adults.
Zullo AR; Zhang T; Lee Y; McConeghy KW; Daiello LA; Kiel DP; Mor V; Berry SD
J Am Geriatr Soc; 2019 Apr; 67(4):768-776. PubMed ID: 30575958
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney Disease.
Goto S; Haas S; Ageno W; Goldhaber SZ; Turpie AGG; Weitz JI; Angchaisuksiri P; Nielsen JD; Kayani G; Farjat A; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK;
JAMA Netw Open; 2020 Oct; 3(10):e2022886. PubMed ID: 33112399
[TBL] [Abstract][Full Text] [Related]
17. Fractures and their sequelae in non-dialysis-dependent chronic kidney disease: the Stockholm CREAtinine Measurement project.
Runesson B; Trevisan M; Iseri K; Qureshi AR; Lindholm B; Barany P; Elinder CG; Carrero JJ
Nephrol Dial Transplant; 2020 Nov; 35(11):1908-1915. PubMed ID: 31361316
[TBL] [Abstract][Full Text] [Related]
18. Osteoporosis, bone mineral density and CKD-MBD: treatment considerations.
Bover J; Bailone L; López-Báez V; Benito S; Ciceri P; Galassi A; Cozzolino M
J Nephrol; 2017 Oct; 30(5):677-687. PubMed ID: 28432640
[TBL] [Abstract][Full Text] [Related]
19. Oral Bisphosphonates Are Associated With Increased Risk of Severe Acute Kidney Injury in Elderly Patients With Complex Health Needs: A Self-Controlled Case Series in the United Kingdom.
Oda T; Jödicke AM; Robinson DE; Delmestri A; Keogh RH; Prieto-Alhambra D
J Bone Miner Res; 2022 Jul; 37(7):1270-1278. PubMed ID: 35579494
[TBL] [Abstract][Full Text] [Related]
20. Effects of osteoporosis medications on bone fracture in patients with chronic kidney disease.
Kao CC; Wu PC; Chuang MT; Yeh SC; Lin YC; Chen HH; Fang TC; Chang WC; Wu MS; Chang TH
Postgrad Med J; 2023 May; 99(1170):340-349. PubMed ID: 37227976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
